Ophthalmology News and Research RSS Feed - Ophthalmology News and Research

CMC Biologics, River Vision sign manufacturing agreement for Teprotumumab to treat Grave's Orbitopathy

CMC Biologics, River Vision sign manufacturing agreement for Teprotumumab to treat Grave's Orbitopathy

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave's Orbitopathy and other indications. [More]
Study explores better treatment options for patients with optic disc pits

Study explores better treatment options for patients with optic disc pits

New research from the University of Alberta's Faculty of Medicine & Dentistry is showing less is more when it comes to the treatment of optic disc pits--a rare eye condition. [More]
Tyrone Regional Health Network signs letter of intent to become member of Penn State Health

Tyrone Regional Health Network signs letter of intent to become member of Penn State Health

Tyrone Regional Health Network and Penn State Health have signed a letter of intent to enter into formal affiliation. With approval by organizational boards and state authorities, Tyrone Regional will become a member of Penn State Health. [More]
UCLA Health's hospitals named among nation's best in U.S. News and World Report

UCLA Health's hospitals named among nation's best in U.S. News and World Report

UCLA Health's hospitals in Westwood and Santa Monica have been named to U.S. News and World Report's 2015-2016 Best Hospitals Honor Roll. UCLA, which previously ranked No. 5 in the country, tied for No. 3 this year. [More]
New study suggests novel ways to treat serous retinal detachment

New study suggests novel ways to treat serous retinal detachment

Wet age-related macular degeneration (AMD) is the leading cause of severe vision loss in older individuals. AMD and other serious chronic eye problems that affect younger individuals result when fluid accumulates abnormally under or within the retina. A new study published in The American Journal of Pathology shows for the first time that the release of substances from mast cells may be a causal factor in this type of eye pathology, and inhibitors of this release may offer new ways to treat serous retinal detachment. [More]
Current and new treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International

Current and new treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International

For two decades beginning in the late 1970’s through 2001, clinicians relied upon laser photocoagulation in the treatment of wet AMD caused by choroidal neovascularization. Attempts to obliterate the neovascular lesions often led to acute central visual loss and often, even with modest success, the lesions recurred with even more vision loss. [More]
Gene therapy used for sight restoration also strengthens visual pathways in the brain

Gene therapy used for sight restoration also strengthens visual pathways in the brain

Since 2007, clinical trials using gene therapy have resulted in often-dramatic sight restoration for dozens of children and adults who were otherwise doomed to blindness. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania and The Children's Hospital of Philadelphia, have found evidence that this sight restoration leads to strengthening of visual pathways in the brain, published this week in Science Translational Medicine. [More]
Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

Gene therapy provides life-long protection to photoreceptor cells in animal model of retinitis pigmentosa

A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse model of the most common inherited eye disorder. [More]
Up-to-date treatment and diagnostic guidelines for diabetic retinal degeneration

Up-to-date treatment and diagnostic guidelines for diabetic retinal degeneration

Around 600,000 Austrians suffer from diabetes. This condition is frequently associated with serious retinal disorders. Along with age-related macular degeneration, diabetic retinal degeneration is one of the most common causes of blindness. The Department of Ophthalmology and Optometry at MedUni Vienna was chosen by the European Society of Retina Specialists (EURETINA) to coordinate the development of up-to-date treatment and diagnostic guidelines. [More]
Retinal function, structure changes in proliferative diabetic retinopathy revealed

Retinal function, structure changes in proliferative diabetic retinopathy revealed

Patients with proliferative diabetic retinopathy exhibit marked visual dysfunction and structural changes in both the inner and outer retinal layers, research findings indicate. [More]

Macular atrophy predicts vision in ranibizumab-treated exudative AMD patients

Progression and severity of macular atrophy are the main anatomical determinants of long-term visual outcomes in exudative age-related macular degeneration patients treated with ranibizumab, suggest SEVEN-UP study results. [More]
Darapladib shows promise in diabetic macular oedema

Darapladib shows promise in diabetic macular oedema

Placebo-controlled trial findings show that lipoprotein-associated phospholipase A2 inhibition modestly benefits the vision of patients with centre-involved diabetic macular oedema and warrants further investigation. [More]
Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks. [More]
Study focuses on health risks from exposure to air pollution near roads and freeways

Study focuses on health risks from exposure to air pollution near roads and freeways

Policymakers and developers planning high-density housing near public transit with the goal of reducing automobile use and greenhouse gas emissions that contribute to global warming need a clearer understanding of the health risks from air pollution that may be created if that housing is also built near busy roads and freeways, according to new research by Keck School of Medicine of the University of Southern California scientists. [More]
Allergan enters into agreement to acquire Oculeve

Allergan enters into agreement to acquire Oculeve

Allergan plc, a leading global pharmaceutical company, and Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease, today announced that they have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction. [More]

UH's Earl L. Smith selected for prestigious National Optometry Hall of Fame

Longtime College of Optometry faculty member and University of Houston administrator Earl L. Smith III, O.D., is a member of an elite group of optometrists who has been selected for the prestigious National Optometry Hall of Fame. [More]
24% rise in the number of clinical trials according to Cell Therapy Catapult annual UK analysis

24% rise in the number of clinical trials according to Cell Therapy Catapult annual UK analysis

The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular. [More]
Practice caution with Fourth of July fireworks, urge Vanderbilt doctors

Practice caution with Fourth of July fireworks, urge Vanderbilt doctors

Fireworks and the Fourth of July can be a dangerous mix. Doctors at Vanderbilt University Medical Center urge caution with consumer fireworks and suggest leaving these displays to the experts. [More]

OCT angiography shows promise in CNV detection

Noninvasive optical coherence tomography angiography can successfully detect choroidal neovascularisation, research findings indicate. [More]
Vitrectomy scatter photocoagulation linked to peripheral thickening in diabetic retinopathy

Vitrectomy scatter photocoagulation linked to peripheral thickening in diabetic retinopathy

Early transient peripheral retinochoroidal thickening following pars plana vitrectomy for proliferative diabetic retinopathy may be related to intraoperative scatter photocoagulation, suggest researchers. [More]
Advertisement
Advertisement